Normal view MARC view ISBD view

Vergnenègre, A

Cost analysis of hospital treatment--two chemotherapic regimens for non-surgical non-small cell lung cancer. GFPC (Groupe Français Pneumo Cancérologie) [electronic resource] - Lung cancer (Amsterdam, Netherlands) Feb 1996 - 31-44 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

ISSN: 0169-5002

Standard No.: 10.1016/0169-5002(95)00511-0 doi

Subjects--Topical Terms:
Adult
Aged
Antibiotics, Antineoplastic--economics
Antineoplastic Agents, Phytogenic--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--economics
Carcinoma, Non-Small-Cell Lung--drug therapy
Cisplatin--economics
Cost-Benefit Analysis
Direct Service Costs--statistics & numerical data
Drug Costs--statistics & numerical data
Female
France
Health Services Research--methods
Hospital Costs--statistics & numerical data
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Mitomycins--economics
Models, Economic
Oncology Service, Hospital--economics
Prospective Studies
Quality-Adjusted Life Years
Retrospective Studies
Sensitivity and Specificity
Treatment Outcome
Vinblastine--analogs & derivatives
Vindesine--economics
Vinorelbine